Temasek backs Google life sciences affiliate

The Singapore state investor’s $800 million investment in San Francisco-based Verily will be used to commercialise the company’s healthcare products in Asia.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this